Wall Street brokerages expect that Integer Holdings Corp (NYSE:ITGR) will post $323.40 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Integer’s earnings. The highest sales estimate is $328.40 million and the lowest is $318.40 million. Integer reported sales of $314.46 million in the same quarter last year, which suggests a positive year-over-year growth rate of 2.8%. The firm is expected to report its next earnings results on Thursday, August 1st.
On average, analysts expect that Integer will report full-year sales of $1.27 billion for the current year. For the next fiscal year, analysts anticipate that the company will report sales of $1.34 billion, with estimates ranging from $1.34 billion to $1.35 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for Integer.
Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, May 2nd. The medical equipment provider reported $1.00 EPS for the quarter, topping the consensus estimate of $0.80 by $0.20. The firm had revenue of $314.70 million during the quarter, compared to the consensus estimate of $302.29 million. Integer had a return on equity of 12.56% and a net margin of 12.88%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.61 earnings per share.
Shares of Integer stock traded up $2.73 on Friday, hitting $74.98. The company had a trading volume of 404,379 shares, compared to its average volume of 246,729. The company has a market cap of $2.45 billion, a PE ratio of 19.73 and a beta of 0.91. Integer has a 1 year low of $57.31 and a 1 year high of $92.61. The company has a quick ratio of 1.37, a current ratio of 2.53 and a debt-to-equity ratio of 0.84.
In related news, SVP Anthony W. Borowicz sold 2,500 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $85.92, for a total value of $214,800.00. Following the sale, the senior vice president now directly owns 18,124 shares of the company’s stock, valued at $1,557,214.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jose Antonio Gonzalez sold 9,088 shares of the firm’s stock in a transaction dated Thursday, February 28th. The stock was sold at an average price of $90.88, for a total value of $825,917.44. Following the completion of the sale, the insider now directly owns 11,899 shares in the company, valued at $1,081,381.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 62,147 shares of company stock valued at $5,358,962. 2.24% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. grew its stake in shares of Integer by 0.6% in the fourth quarter. BlackRock Inc. now owns 4,795,926 shares of the medical equipment provider’s stock worth $365,737,000 after purchasing an additional 27,719 shares during the last quarter. Vanguard Group Inc grew its stake in shares of Integer by 4.2% in the third quarter. Vanguard Group Inc now owns 3,278,299 shares of the medical equipment provider’s stock worth $271,935,000 after purchasing an additional 131,450 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Integer by 4.2% in the third quarter. Vanguard Group Inc. now owns 3,278,299 shares of the medical equipment provider’s stock worth $271,935,000 after purchasing an additional 131,450 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of Integer by 0.8% in the fourth quarter. Fisher Asset Management LLC now owns 1,202,218 shares of the medical equipment provider’s stock worth $91,681,000 after purchasing an additional 9,362 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Integer by 1.4% in the third quarter. Bank of New York Mellon Corp now owns 488,808 shares of the medical equipment provider’s stock worth $40,547,000 after purchasing an additional 6,914 shares during the last quarter. 94.66% of the stock is currently owned by institutional investors.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Recommended Story: Certificate of Deposit (CD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.